XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 26,089 $ 19,835
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for credit losses 1,875 2,587
Depreciation and amortization 1,414 1,381
Amortization and accretion of loans and other assets (2,691) (3,157)
Amortization and accretion of investment securities 547 1,111
Deferred income taxes 547 1,296
Equity securities gains, net (56) (127)
Earnings on bank owned life insurance (1,064) (1,334)
Vesting of restricted stock 296 208
Originations of loans held for sale (117,364) (120,486)
Proceeds from sales of loans held for sale 115,131 117,904
Realized gains on loans sold (1,720) (1,648)
Realized gains on sale of Braavo 0 (1,102)
(Increase) decrease in accrued interest receivable (1,105) 240
Loss on sale of foreclosed assets held for sale (9) (93)
(Decrease) increase in accrued interest payable (939) 1,251
Other, net (1,147) 4,833
Net cash provided by operating activities 19,804 22,699
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from maturity and principal repayments 55,149 42,699
Purchase of securities (68,404) (36,222)
Proceeds from sale of equity securities 0 335
Purchase of interest bearing time deposits with other banks 0 (100)
Proceeds from matured interest bearing time deposits with other banks 0 350
Proceeds from life insurance 272 1,147
Proceeds from redemption of regulatory stock 24,124 23,870
Purchase of regulatory stock (24,290) (19,552)
Net increase in loans (19,386) (88,325)
Purchase of premises and equipment (1,225) (852)
Proceeds from sale of premises and equipment 13 0
Proceeds from sale of foreclosed assets held for sale 170 567
Proceeds from sale of Braavo assets 0 7,185
Net cash used in investing activities (33,577) (68,898)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net increase in deposits 29,175 128,669
Repayments of long-term borrowings (37,000) (10,000)
Net increase (decrease) in short-term borrowed funds 17,942 (81,351)
Purchase of treasury and restricted stock (373) (204)
Sale of stock for ESPP 48 0
Dividends paid (7,146) (6,970)
Net cash provided by financing activities 2,646 30,144
Net decrease in cash and cash equivalents (11,127) (16,055)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 42,202 52,818
CASH AND CASH EQUIVALENTS AT END OF PERIOD 31,075 36,763
Supplemental Disclosures of Cash Flow Information:    
Interest paid 47,166 49,690
Income taxes paid 4,000 1,500
Loans transferred to foreclosed property 40 2,486
Right of use asset and liability 702 306
Stock Dividend $ 2,844 $ 2,047